Drug Trial Radar · NCT00803686
A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women
Last checked: Nov 20, 2026Latest source record: Jun 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
12
Actual
Start
Dec 2008
Primary completion
Jan 2009
Study completion Jan 2009
Sponsor
- Lead sponsor
- Tarsa Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 5, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- Female only, from 45 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is being conducted to assess the plasma CTx-1 concentrations when dosing is at night and to compare these results with those obtained with a placebo control and with commercially available nasal calcitonin.
Conditions
- Phase 1 Pharmacodynamic Study
Interventions
Oral rsCT tabletDrug
On Study Day 1, subjects will be given their assigned treatment, based on one of two randomly ordered treatment sequences, at 10 PM (22:00). On Visit 3, subjects will return for administration of the second treatment with a minimum of 7 days washout interval between study drug administrations. On Visit 4, subjects will return for administration of third treatment of rsCT, either oral rsCT tablets or Fortical (rsCT) nasal spray. Interventions are described in Intervention Name, Other Names and in Intervention Description.
Oral Placebo TabletDrug
Part 1, Double blind oral placebo tablet given once 4 hours after evening meal.
Oral rsCT tabletDrug
Part 2, Open-label, oral rsCT tablet given once 2 hours after the evening meal.
Fortical (rsCT) nasal sprayDrug
Intervention: Open label, Fortical nasal spray given once 2 hours after the evening meal.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacodynamic Effect of Oral CalcitoninTime frame: 12 hr
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Bio-Kinetic Clinical Applications, Inc.
Springfield, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.